Correlations and diagnostic tools for metabolic syndrome (MetS) and chronic obstructive pulmonary disease (COPD).

International journal of physiology, pathophysiology and pharmacology Pub Date : 2022-01-01

Mahshid Bahrami, Khatereh Forouharnejad, Hannaneh Mirgaloyebayat, Nadia Ghasemi Darestani, Mozhgan Ghadimi, Dorna Masaeli, Pooya Fazeli, Hossein Mohammadi, Mahdi Shabani, Mohammad Emami Ardestani

{"title":"Correlations and diagnostic tools for metabolic syndrome (MetS) and chronic obstructive pulmonary disease (COPD).","authors":"Mahshid Bahrami, Khatereh Forouharnejad, Hannaneh Mirgaloyebayat, Nadia Ghasemi Darestani, Mozhgan Ghadimi, Dorna Masaeli, Pooya Fazeli, Hossein Mohammadi, Mahdi Shabani, Mohammad Emami Ardestani","doi":"","DOIUrl":null,"url":null,"abstract":"Background: Regarding the importance of obesity in patients with chronic obstructive pulmonary disease (COPD), we aimed to evaluate of correlation between metabolic syndrome (MetS) and COPD.Methods: In this cross-sectional study, 96 patients with COPD were evaluated. This study was conducted in 2016-2018. The severity of COPD was determined by Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 criteria. We investigated the correlations between MetS with COPD and possible diagnostic tools.Results: Of all COPD patients, 86.5% had MetS, and the means of waist circumference, fasting blood glucose, systolic and diastolic blood pressure, body mass index, and triglyceride in patients with MetS were significantly higher than the patients without MetS (P < 0.05). We showed that forced expiratory volume in 1 second (FEV1) with a 37% cutoff had 92.8% and 69.2% sensitivity and specificity, respectively (area of the curve: 0.51, 0.31-0.71).Conclusion: MetS is prevalent among COPD and FEV1 could be considered as important diagnostic tool for COPD.","PeriodicalId":14352,"journal":{"name":"International journal of physiology, pathophysiology and pharmacology","volume":"14 6","pages":"311-315"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890204/pdf/ijppp0014-0311.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of physiology, pathophysiology and pharmacology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Regarding the importance of obesity in patients with chronic obstructive pulmonary disease (COPD), we aimed to evaluate of correlation between metabolic syndrome (MetS) and COPD.

Methods: In this cross-sectional study, 96 patients with COPD were evaluated. This study was conducted in 2016-2018. The severity of COPD was determined by Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 criteria. We investigated the correlations between MetS with COPD and possible diagnostic tools.

Results: Of all COPD patients, 86.5% had MetS, and the means of waist circumference, fasting blood glucose, systolic and diastolic blood pressure, body mass index, and triglyceride in patients with MetS were significantly higher than the patients without MetS (P < 0.05). We showed that forced expiratory volume in 1 second (FEV1) with a 37% cutoff had 92.8% and 69.2% sensitivity and specificity, respectively (area of the curve: 0.51, 0.31-0.71).

Conclusion: MetS is prevalent among COPD and FEV1 could be considered as important diagnostic tool for COPD.

微信好友朋友圈 QQ好友复制链接

本刊更多论文

代谢综合征(MetS)和慢性阻塞性肺疾病(COPD)的相关性和诊断工具。

背景:考虑到肥胖在慢性阻塞性肺疾病(COPD)患者中的重要性，我们旨在评估代谢综合征(MetS)与COPD之间的相关性。方法:在本横断面研究中，对96例COPD患者进行评估。这项研究是在2016-2018年进行的。COPD的严重程度由全球慢性阻塞性肺疾病倡议(GOLD) 2017标准确定。我们研究了MetS与COPD之间的相关性以及可能的诊断工具。结果:86.5%的COPD患者存在MetS，且met患者的腰围、空腹血糖、收缩压、舒张压、体重指数、甘油三酯均值均显著高于无MetS患者(P < 0.05)。我们发现，1秒用力呼气量(FEV1)的临界值为37%，其敏感性和特异性分别为92.8%和69.2%(曲线面积:0.51,0.31-0.71)。结论:MetS在COPD患者中普遍存在，FEV1可作为COPD的重要诊断工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

International journal of physiology, pathophysiology and pharmacology

自引率

0.00%

发文量